Back

JYP · Lens · Synthetic and in vivo Antiepileptic Activity of “Benzene Sulfonic Acid and its Derivatives”

PDF

Article · Volume 16, Issue 1 · pp. 24–32

Synthetic and in vivo Antiepileptic Activity of “Benzene Sulfonic Acid and its Derivatives”

Rohit Jaysing Bhor1, Sanket Satish Patare1, Rahul Bapusaheb Shirole1, Karan Suresh Kadam1, Mahesh Hari Kolhe3, Rajshree Ghogare2

  1. 1Department of Pharmaceutical Chemistry, Pravara Rural College of Pharmacy, Pravaranagar, Rahata, Ahmednagar, Maharashtra, INDIA.
  2. 2Department of Pharmacology, Pravara Rural College of Pharmacy, Pravaranagar, Rahata, Ahmednagar, Maharashtra, INDIA.
  3. 3Department of Pharmacutices, Pravara Rural College of Pharmacy, Pravaranagar, Rahata, Ahmednagar, Maharashtra, INDIA.

Abstract

Background: A heterocyclic hydrocarbon having a 5, 5-diphenylimidazolidine heterocyclic ring that possesses distinctive fundamental structural characteristics. It is a fused ring of aromatic di-benzene and imidazolidine. The flexible heterocyclic molecules in 5, 5-diphenylimidazolidine that have two nitrogen atoms. The biological activity of the 5, 5-diphenylimidazolidine ring and its derivatives is significant and encouraging. We produce a variety of 4-(chloroethoxy)-3- [2,4-dioxo-5,5-diphenylimidazolidine-1-yl) carbonyl] benzene sulfonic acid and its derivatives in this investigation. In literature survey and molecular docking; it was confirmed that 5, 5-diphenylimidazolidine-2,4-dione gives anticonvulsant effects. The pharmacological samples were examined for their ability to prevent convulsions using the strychnine-induced convulsion method.Materials and Methods: Benzoin; Benzil; Urea; Glacial Acetic Acid; 4- Amino Benzoic Acid; Con. HNO3; Formic Acid; 2- Nitro Aniline; 4- Nitro Aniline; Aniline; Acetyl Chloride; Formic Acid; 4- amino Phenol are used for the synthesis.IR, NMR and MS are used for interpretation.Results: Our research led us to the conclusion that a variety of compounds have strong anticonvulsant properties. The compound 4-(2-chloro-N-(2-phenoxyethyl) aniline)-3-[2,4-dioxo-5,5-diphenylimidazolidine-1-yl) carbonyl] sulfonic acid (SPD5)- (scheme II A); 4-(3-chloro-N-(2-phenoxyethyl)aniline)-3-[2,4-dioxo-5,5-diphenylimidazolidine-1-yl) carbonyl] sulfonic acid (SPD6)- (scheme II A); 4-(2,5-dichloro-N-(2-phenoxyethyl)aniline)- 3-[2,4-dioxo-5,5-diphenylimidazolidine-1-yl) carbonyl] sulfonic acid (SPD7) (scheme II A) and 4-(N-(2-phenoxyethyl)aniline)-3-[2,4-dioxo-5,5-diphenylimidazolidine-1-yl) carbonyl] sulfonic acid (SPD3) (scheme II A) gives strong anti-convulsant effects against phenytoin drug.Conclusion: The title compounds and their derivatives were examined for their ability to treat convulsions. Studies of the relationship between structure and activity revealed that compounds containing 5, 5-diphenylimidazolidine derivatives that have an electron-withdrawing group have higher activity than those that have an electron-donating group.

Keywords: 5; 5-diphenylimidazolidine; Benzil; Urea; 4- amino benzoic acid; 2- Nitro Aniline; 4- Nitro Aniline; Aniline; Strychnine; Anti-Convulsant Activity; Phenytoin

The full text of this article is available as a PDF. Open the PDF.